ELRIG’s Drug Discovery 2026 is back at London’s ExCel (London Exhibition Centre), and as Europe’s leading drug discovery and life sciences conference, it will have scientific tracks covering topics including Next Generation biophysics, microbes to medicines, multiomics, AI in compound discovery and in experimental design, and bioconjugation approaches in oncology.
This conference marks 20 years of ELRIG Drug Discovery and will have keynote sessions both reflecting on the past and looking towards the future. Once again, we will be hosting scientific content from partners such as SLAS, CRUK, The Microbiology Society, British Neuroscience Association and the Royal Society of Chemistry. The exhibition hall will provide attendees the opportunity to meet with, engage and learn from the leaders in drug discovery as well as leading product and service suppliers.
ELRIG aims to remove as many barriers to conference attendance as possible, so all events are free to attend and have a faith room, family room and quiet room available, ensuring our promise of inclusivity is at the heart of all our events.
REPROCELL at ELRIG Drug Discovery 2026
REPROCELL will be exhibiting at this show. Please stop by our booth #B21 and say hi to our team: David, Abbie, and Ella-Rose to learn our services.
We look forward to seeing you in Liverpool, UK! Let us tell you about our capabilities. We may be a good partner for your next projects.
Technology Spotlight Company Presentation
- Subject: TBD
- Presenter: Dr David Bunton, CEO, REPROCELL Europe Ltd.
- Date: TBD
- Location: TBD
REPROCELL staff at Booth#B21
- Dr David Bunton (david.bunton@reprocell-europe.com)
CEO, REROCELL Europe Ltd. - Abbie Wishart (abbie.wishart@reprocell-europe.com)
Business Development Manager - Ella-Rose Johnson (Ella-Rose.Johnson@reprocell-europe.com)
Scientific Sales Associate